OTCMKTS:DGNOF DIAGNOS - DGNOF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.27 +0.01 (+2.76%) (As of 03/22/2023) Add Compare Share Share Today's Range$0.27▼$0.2750-Day Range$0.22▼$0.3252-Week Range$0.11▼$0.32Volume7,500 shsAverage Volume6,705 shsMarket Capitalization$19.17 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsShort Interest About DIAGNOS (OTCMKTS:DGNOF) StockDiagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company offers algorithm development, data analysis, and image processing services. It focuses on the development of its AI tool, Computer Assisted Retina Analysis, which is a tele-ophthalmology platform that integrates with existing equipment and processes at the point of care. The company was founded by Djamel Abdelkader Zighed in 1998 and is headquartered in Brossard, Canada.Read More Receive DGNOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address DGNOF Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive DGNOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address DGNOF Company Calendar Today3/26/2023Fiscal Year End3/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private households Sub-IndustryN/A SectorBusiness Services Current SymbolOTCMKTS:DGNOF CUSIPN/A CIKN/A Webwww.diagnos.ca Phone(450) 678-8882FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,080,000.00 Net Margins-445.58% Pretax Margin-445.35% Return on Equity-30,389.99% Return on Assets-235.56% Debt Debt-to-Equity RatioN/A Current Ratio0.81 Quick Ratio0.81 Sales & Book Value Annual Sales$350,000.00 Price / Sales54.77 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares70,610,000Free FloatN/AMarket Cap$19.17 million OptionableNot Optionable Beta0.66 Key ExecutivesAndré M. LarentePresident, Chief Executive Officer & DirectorMarc-André MassueChief Financial Officer, Secretary & VP-FinanceRiadh KobbiVice President-Business IntelligenceGuillermo Moreno RoblesVice President-SalesYves-Stéphane CoutureVice President-SalesKey CompetitorsVictory Square TechnologiesOTCMKTS:VSQTFVoyager DigitalOTCMKTS:VYGVFReliq Health TechnologiesOTCMKTS:RQHTFATIFNASDAQ:ATIFBTCSOTCMKTS:BTCSView All Competitors DGNOF Stock - Frequently Asked Questions How have DGNOF shares performed in 2023? DIAGNOS's stock was trading at $0.2156 at the beginning of 2023. Since then, DGNOF shares have increased by 26.0% and is now trading at $0.2715. View the best growth stocks for 2023 here. Are investors shorting DIAGNOS? DIAGNOS saw a drop in short interest in the month of February. As of February 15th, there was short interest totaling 500 shares, a drop of 95.8% from the January 31st total of 11,900 shares. Based on an average trading volume of 7,800 shares, the short-interest ratio is presently 0.1 days. View DIAGNOS's Short Interest. What is DIAGNOS's stock symbol? DIAGNOS trades on the OTCMKTS under the ticker symbol "DGNOF." How do I buy shares of DIAGNOS? Shares of DGNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is DIAGNOS's stock price today? One share of DGNOF stock can currently be purchased for approximately $0.27. How much money does DIAGNOS make? DIAGNOS (OTCMKTS:DGNOF) has a market capitalization of $19.17 million and generates $350,000.00 in revenue each year. The company earns $-2,080,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. How can I contact DIAGNOS? DIAGNOS's mailing address is 7005 Taschereau Boulevard Suite 340, Brossard A8, J4Z 1A7. The official website for the company is www.diagnos.ca. The company can be reached via phone at (450) 678-8882. This page (OTCMKTS:DGNOF) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.